Rian Hollister: PlasmaFlow As An Option for Continued DVT Prevention
Rian Hollister, Territory Manager at Recon Supply, shared on LinkedIn:
”To all my fellow veterans, ask your VA providers/staff about PlasmaFlow as an option for continued DVT prevention from hospital/medical facility to home.
‘U.S. Centers for Medicare and Medicaid Services (CMS) declared deep vein thrombosis (DVT) a Never Event in 2008, yet it remains the leading cause of preventable death in hospitalized patients each year.’
‘The PlasmaFlow™ Portable Compression Device can reduce DVT risk by providing hospital-quality vascular compression therapy to patients wherever they recover.
DVT risk doesn’t end when a patient is discharged.
With more high-risk surgeries moving from inpatient to outpatient settings, effective compression therapy after discharge is critical.
CHEST guidelines recommend extending thromboprophylaxis in the outpatient period for up to 35 days from the day of surgery for patients undergoing major orthopedic surgery.’
- 60% of HA-VTEs occur after patients have been discharged.
- As many as 70% of HA-VTE cases in patients could be prevented.
“Healthcare-associated venous thromboembolism (HA-VTE) leads to approximately 100,000 premature deaths annually.”
Mean time to presentation for symptomatic DVT:
Total Knee Arthroplasty (TKA) patients = 19.5 days
Total Hip Arthroplasty (THA) patients = 22.5 days
‘The PlasmaFlow™ Portable Compression Device provides continuous DVT prevention for patients returning home to recover.
This portable compression device is comfortable and convenient, ensuring better protection for patients and peace of mind for providers.”’
Stay updated with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?